![](/img/cover-not-exists.png)
A phase II study of bendamustine plus rituximab in Japanese patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma previously treated with rituximab: BRB study
Matsumoto, Kimihiro, Takayama, Nobuyuki, Aisa, Yoshinobu, Ueno, Hironori, Hagihara, Masao, Watanabe, Kentaro, Nakaya, Aya, Chen, Kenko, Shimizu, Takayuki, Tsukada, Yuiko, Yamada, Yuji, Nakazato, TomonVolume:
101
Language:
english
Journal:
International Journal of Hematology
DOI:
10.1007/s12185-015-1767-3
Date:
June, 2015
File:
PDF, 268 KB
english, 2015